Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425127 (3,5-dimethyl-4-[3-(2- pyrrolidin-1-ylethyl)-1H-ind...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425130 (4-[3-[methoxy-[6-(trifluoromethyl)- 3-pyridyl]meth...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425134 (3,5-dimethyl-4-(2-methyl-1H- pyrrolo[2,3-b]pyridin...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425145 (US10519177, Compound P-0025 | [5-(3,5-dimethylisox...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425156 (4-(1-butylsulfonylpyrrolo [3,2-b]pyridin-6-yl)- 3,...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425158 (4-[1-(benzenesulfonyl) pyrrolo[3,2-b]pyridin- 6-yl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425162 ((2-chlorophenyl)-[5-(3,5- dimethylisoxazol-4-yl)-2...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425163 (US10519177, Compound P-0043 | [5-(3,5-dimethylisox...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425166 (3,5-dimethyl-4-[3- [[3-(trifluoromethoxy) phenyl]m...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425167 (4-[3-[[2-(difluoro- methoxy)phenyl]methyl]- 1H-pyr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425731 (4-[6-(3,5-dimethylisoxazol-4-yl)-1- [(6-methoxy-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425735 (4-[3-iodo-1-(4- pyridylmethyl)pyrrolo[3,2- b]pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425738 (4-[6-(3,5-dimethylisoxazol-4-yl)-1- [(1S)-1-(2- py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425746 (2-[4-[6-(3,5-dimethylisoxazol-4- yl)-1-[(4-methylt...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425753 (4-[6-(3,5-dimethylisoxazol-4-yl)-1- (2-pyridylmeth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425170 (4-[2-ethyl-3-[[3- (trifluoromethoxy)phenyl] methyl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.05E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425175 (3,5-dimethyl-4-[1-(2- thienylsulfonyl)pyrrolo [3,2...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425182 (3,5-dimethyl-4-[1- [(5-methyl-2-thienyl) sulfonyl]...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425189 (4-[3-[cyclopropyol(methoxy)methyl]- 1H-pyrrolo[3,2...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425198 (4-[3-[(4,4-difluoro- cyclohexyl)-methoxy- methyl]-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425216 (US10519177, Compound P-0094) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425217 (US10519177, Compound P-0095) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425221 (4-[[5-(3,5-dimethylisoxazol- 4-yl)-1H-pyrrolo[2,3-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425223 ((4,4- difluorocyclohexyl)- [5-(3,5- dimethylisoxaz...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425231 (4-[1-(benzenesulfonyl)-3-(1- methylpyrazol-4-yl)py...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425241 (1-[4[[5-(3,5- dimethylisoxazol-4-yl)-1- methyl-pyr...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425242 (4-[1-(2-fluorophenyl) sulfonyl-3-(1-methyl- pyrazo...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425256 (4-[3-[1-(difluoro- methyl)pyrazol-4-yl]- 1-propyls...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425259 (4-[3-(1-allylpyrazol- 4-yl)-1-sec-butyl- sulfonyl-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425265 (3,5-dimethyl-4-(3- phenylsulfanyl-1H- pyrrolo[2,3-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425266 (4-[3-(benzenesulfonyl)-1H- pyrrolo[2,3-b]pyridin-5...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425272 (4-[1-cyclopentyl- sulfonyl-3-[1-(2- methoxyethyl)p...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425273 (4-[3-[1-(2-methoxy- ethyl)pyrazol-4-yl]-1- propyls...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425274 (4-[1-cyclopentyl- sulfonyl-3-(1- tetrahydrofuran-3...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425287 (4-(3-diphenylphosphoryl-1H- pyrrolo[2,3-b]pyridin-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425291 (3,5-dimethyl-4-[3-(1-methylpyrazol-4-yl)-1- [(2-me...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425300 (4-[3-(benzenesulfonyl)-1- (oxetan-3-yl)pyrrolo[2,3...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425311 (4-[1-[(2-chloro-5-fluoro-phenyl)methyl]-3-(1- meth...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425321 (4-[3-(1-ethylpyrazol-4-yl)- 1-(1-phenylethyl)pyrro...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425326 (4-[3-(1,3-dimethylpyrazol-4- yl)-1-(1-phenylethyl)...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425333 (US10519177, Compound P-0212) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425334 (4-[1-[(3,3- difluorocyclobutyl)methyl]-3- (1-methy...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425331 (4-[1-[(4,4- difluorocyclohexyl)methyl]-3- [1-(difl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425352 (4-[1-[dideuterio-(3,3- difluorocyclobutyl)methyl]-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425353 (4-[1-[dideuterio-(3,3- difluorocyclobutyl)methyl]-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425361 (3-cyclopentyl-3-[6-(3,5- dimethylisoxazol-4-yl)-3-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425362 (3,5-dimethyl-4-[1-(1-phenylethyl)-3- (3-pyridyl)py...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425364 (4-[3-(4-chlorophenyl)-1-(1- phenylethyl)pyrrolo[3,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [1-477] (Homo sapiens (Human)) | BDBM425370 (4-[3-(2-methoxypyrimidin-5-yl)-1-(1- phenylethyl)p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 4 [44-164] (Homo sapiens (Human)) | BDBM425371 (5-[6-(3,5-dimethylisoxazol-4-yl)-1-(1- phenylethyl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Plexxikon Inc. US Patent | Assay Description Binding of compounds of formula (I) with bromodomain 2, 3 4 was assessed using Alphascreen binding assay. The inhibition of the interaction between b... | US Patent US10519177 (2019) BindingDB Entry DOI: 10.7270/Q2154KDK | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 802 total ) | Next | Last >> |